Forget RNA drugs. Accent gets $40M to develop small molecules that modify RNA instead

Retrieved on: 2018-05-17 17:00:00

Tags for this article:

Biology

Biotechnology

Click the tags to see associated articles and topics

Forget RNA drugs. Accent gets $40M to develop small molecules that modify RNA instead. View article details on hiswai:

Excerpt

<div>This Series A, backed by The Column Group, <b>Atlas Venture</b> and EcoR1 Capital, should get the company “quite far in preclinical discovery.” For now ...</div>

Article found on:

View Original Article